Pharmaceuticals
BF Biosciences Limited, a biotech firm, currently in an uptrend with RSI near 60 and trading above its 50‑day average.
Why now: Recent positive trial data and the upcoming AGM could spark buying, short‑term momentum likely to push price toward the upper half of its 52‑week range.
Risk: Any negative regulatory feedback could stall the rally.
At pick
129.90
Buy zone
126.00 - 129.90
Target
137.69